Anzeige
Mehr »
Donnerstag, 11.06.2026 - Börsentäglich über 12.000 News
Vier Bohrlöcher, vier Treffer - bestätigt sich hier ein neues Uran-System?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.05.Gilead teams up with WHO again to eliminate parasitic tropical disease
21.05.Eli Lilly maintains M&A streak with $202m Engage Bio buyout
21.05.FUJIFILM opens new iPSC facility in Madison, US
21.05.BMS and Anthropic collaborate for Claude implementation
20.05.Investment giants join forces to form largest healthcare firm on the globe
20.05.Clinical Trials Day 2026: 'Research Rising' theme reflected in Q1 study growth
20.05.Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
20.05.QIAGEN and NVIDIA partner on AI drug discovery
20.05.SERB signs agreement to acquire Idefirix rights for $133.6m
19.05.UK government bolsters antiviral supply for hantavirus
19.05.VERTANICAL's VER-01 gains FDA breakthrough status for low back pain
19.05.Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates
18.05.Vaccine void means current Ebola outbreak declared international emergency
18.05.Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup
18.05.Japan's MHLW approves Boehringer's Jascayd for IPF and PPF
18.05.FDA approves Enhertu for two HER2-positive early breast cancer indications
15.05.Nonprofits join forces to debut marketplace for shelved CGTs
15.05.Arna Pharma and Slate Run complete JV for new US company
15.05.Biopharma industry endorses Pazdur for FDA commissioner role
15.05.Kyowa Kirin secures FDA approval for Crysvita dosing update
14.05.UK health secretary Wes Streeting resigns
14.05.Coya Therapeutics secures FDA fast track status for COYA 302
14.05.Regulatory round-up: A month of key FDA approvals for cancer drugs
14.05.Imfinzi set to become first immunotherapy for stomach cancer patients on NHS
14.05.Zydus to acquire Assertio in $166m deal